-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bsp4VTe1JvrRtP+9yaSC9gWUs83kbt6mly+Wi80fRjEzsAwfjayP6ivoy/l4okdz IKuDgS2nVx2z0RHuEccEjQ== 0001209191-07-006543.txt : 20070131 0001209191-07-006543.hdr.sgml : 20070131 20070131211252 ACCESSION NUMBER: 0001209191-07-006543 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20070125 FILED AS OF DATE: 20070131 DATE AS OF CHANGE: 20070131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 845-425-7100 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COHEN STEVEN A/SAC CAPITAL MGMT LP CENTRAL INDEX KEY: 0000905226 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569781 BUSINESS ADDRESS: STREET 1: C/O SAC CAPITAL ADVISORS LLC STREET 2: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2038902153 MAIL ADDRESS: STREET 1: C/O SAC CAPITAL ADVISORS LLC STREET 2: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGMA CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001167507 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569782 BUSINESS ADDRESS: STREET 1: 777 LONG RIDGE ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2036142094 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CR Intrinsic Investors, LLC CENTRAL INDEX KEY: 0001316388 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569783 BUSINESS ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-890-2153 MAIL ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: S A C CAPITAL MANAGEMENT L L C CENTRAL INDEX KEY: 0001015076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569784 BUSINESS ADDRESS: STREET 1: C/O 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2036142056 MAIL ADDRESS: STREET 1: C/O 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAC CAPITAL ADVISORS LLC CENTRAL INDEX KEY: 0001018103 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569785 BUSINESS ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2036142000 MAIL ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 3/A 1 bny29724_bny3sac.xml MAIN DOCUMENT DESCRIPTION X0202 3/A 2007-01-25 2006-01-29 0 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001018103 SAC CAPITAL ADVISORS LLC 72 CUMMINGS POINT ROAD STAMFORD CT 06902 0 0 1 0 0001015076 S A C CAPITAL MANAGEMENT L L C 72 CUMMINGS POINT ROAD STAMFORD CT 06902 0 0 1 0 0001316388 CR Intrinsic Investors, LLC 72 CUMMINGS POINT ROAD STAMFORD CT 06902 0 0 1 0 0001167507 SIGMA CAPITAL MANAGEMENT LLC 72 CUMMINGS POINT ROAD STAMFORD CT 06902 0 0 1 0 0000905226 COHEN STEVEN A/SAC CAPITAL MGMT LP 72 CUMMINGS POINT ROAD STAMFORD CT 06902 0 0 1 0 Common Stock 3007900 I See Footnote Call (right to buy) 25 2007-01-29 2007-01-17 Common Stock 202000 I See Footnote Call (right to buy) 30 2007-01-29 2007-05-19 Common Stock 396300 I See Footnote Call (right to buy) 35 2007-01-29 2008-01-19 Common Stock 22000 I See Footnote See Exhibit 99.2, item 1. See Exhibit 99.2, item 2 See Exhibit 99.2, item 3 See Exhibit 99.1 This Form 3 was amended to accurately reflect CR Intrinsic Investors, LLC as a reporting person. Exhibit List Exhibit 99.1 - Joint Filer Information Exhibit 99.2 - Supplemental Information /s/ Peter Nussbaum, as Authorized Person on behalf of S.A.C. Capital Advisors, LLC 2007-01-31 /s/ Peter Nussbaum, as Authorized Person on behalf of S.A.C. Capital Management, LLC 2007-01-31 /s/ Peter Nussbaum, as Authorized Person on behalf of CR INTRINSIC INVESTORS, LLC 2007-01-31 /s/ Peter Nussbaum, as Authoriized Person on behalf of SIGMA CAPITAL MANAGEMENT, LLC 2007-01-31 /s/ Peter Nussbaum, as Authorized Person on behalf of STEVEN A. COHEN 2007-01-31 EX-99 2 form3exh991.htm ADDITIONAL EXHIBITS
Exhibit 99.1 - Form 3 Joint Filer Information
Name: S.A.C. Capital Management, LLC
Address: 540 Madison Avenue, New York NY 10022
Designated Filer: S.A.C. Capital Advisors, LLC
Issuer & Ticker Symbol: Par Pharmaceutical Companies, Inc. (“PRX”)
Date of Event Requiring Statement: January 25, 2007
Name: CR Intrinsic Investors, LLC
Address: 72 Cummings Point Road, Stamford CT 06902
Designated Filer: S.A.C. Capital Advisors, LLC
Issuer & Ticker Symbol: Par Pharmaceutical Companies, Inc. (“PRX”)
Date of Event Requiring Statement: January 25, 2007
Name: Sigma Capital Management, LLC
Address: 540 Madison Avenue, New York NY 10022
Designated Filer: S.A.C. Capital Advisors, LLC
Issuer & Ticker Symbol: Par Pharmaceutical Companies, Inc. (“PRX”)
Date of Event Requiring Statement: January 25, 2007
Name: Steven A. Cohen
Address: 72 Cummings Point Road, Stamford CT 06902
Designated Filer: S.A.C. Capital Advisors, LLC
Issuer & Ticker Symbol: Par Pharmaceutical Companies, Inc. (“PRX”)
Date of Event Requiring Statement: January 25, 2007

 

EX-99 3 form3exh992.htm ADDITIONAL EXHIBITS
Exhibit 99.2 - Supplemental Information
(1) S.A.C. Capital Associates, LLC (“Associates”), C.R. Intrinsic Investments, LLC (“Intrinsic Investments”), and Sigma Capital Associates, LLC (“Sigma Associates”), each an Anguillan limited liability company, directly each own Common Stock of the Issuer and/or call options to purchase Common Stock of the Issuer. At 12:48 p.m., Eastern Standard Time, on January 25, 2007, Associates had direct beneficial ownership of, and each of S.A.C. Capital Advisors, LLC (“Advisors”) and S.A.C. Capital Management (“Management”) had indirect beneficial ownership of, 2,115,000 shares of Common Stock of the Issuer; Intrinsic Investments had direct beneficial ownership of, and C.R. Intrinsic Investors, LLC (“Intrinsic Investors”) had indirect beneficial ownership of, 1,082,800 shares of Common Stock of the Issuer; Sigma Associates had direct beneficial ownership of, and Sigma Capital Management, LLC (“Sigma Management”) had indirect beneficial ownership of, 430,400 shares of Common Stock of the Issuer; and Steven A. Cohen had indirect beneficial ownership of 3,628,200 shares of Common Stock of the Issuer. For purposes of this filing, the Reporting Persons have calculated the aggregate number of outstanding shares of the Issuer’s Common Stock as 35,956,798, based on the Form 10-Q, dated December 21, 2006.
(2) The securities to which this report relates are held by Associates, Intrinsic Investments, and Sigma Associates. Advisors and Management are investment managers to Associates; Intrinsic Investors is an investment manager to Intrinsic Investments; and Sigma Management is an investment manager to Sigma Associates. Pursuant to investment agreements, (i) each of Advisors and Management share all investment and voting power with respect to the securities held by Associates, (ii) Intrinsic Investors maintains investment and voting power with respect to the securities held by Intrinsic Investments, and (iii) Sigma Management maintains investment and voting power with respect to the securities held by Sigma Associates. Steven A. Cohen controls each of Advisors, Management, Intrinsic Investors, and Sigma Management. Intrinsic Investments is a wholly owned subsidiary of Associates. In accordance with Instruction 5(b)(iv), the entire amount of the Issuer’s securities held by Associates, Intrinsic Investments, and Sigma Associates is reported herein. The Reporting Persons disclaim any beneficial ownership of any of the Issuer’s securities to which this report relates for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
(3) Each of these call options are currently exerciseable and became exerciseable immediately upon purchase.

 

-----END PRIVACY-ENHANCED MESSAGE-----